The best Stockopedia alternative in 2026 is ScreenerHero. It covers all major European exchanges — including microcaps on Euronext Growth, Nasdaq First North, and EGM Milan — plus US and Canadian stocks, at €29/month. That is less than half the price of Stockopedia's €80/month plan that includes US equities, and less than the €60/month plan that doesn't.
Last updated: July 2026.
Why investors look for Stockopedia alternatives
Stockopedia has a loyal following, particularly among UK-based value and GARP investors. Its StockRanks system — combining Quality, Value, and Momentum scores into a single composite ranking — is genuinely thoughtful. But three friction points drive users to look for alternatives:
1. Price has become harder to justify. At €60/month for Europe-only or €80/month for US + Europe, Stockopedia is the most expensive retail-focused fundamental screener in this comparison. Users who primarily need a fast, reliable filter interface — rather than the full editorial and report ecosystem — often conclude they are paying for features they don't use.
2. US stocks require the most expensive plan. If you want to screen both European and US stocks in Stockopedia, you must be on the €80/month plan. Investors who split their attention between markets pay a significant premium for this combination.
3. Continental European microcap coverage is uneven. Stockopedia is UK-weighted in its data quality. Coverage of alternative markets — Euronext Growth Paris, Nasdaq First North, EGM Milan, GPW NewConnect — is inconsistent. French, Italian, and Nordic small-cap investors report frequent data gaps for the names that matter most to their strategies.
Stockopedia alternatives compared
| Feature | Stockopedia (EU) | Stockopedia (US+EU) | ScreenerHero | TIKR Pro | MarketScreener |
|---|---|---|---|---|---|
| Price/month | €60 | €80 | €29 | $40–55 | ~€30–34 |
| Free no-account tier | ✗ | ✗ | ✓ | ✗ | Partial |
| EU large cap | ✓ | ✓ | ✓ | ✓ | ✓ |
| EU microcap / alternative markets | Partial (UK-heavy) | Partial | ✓ | Listed, gaps | Partial |
| US stocks | ✗ | ✓ | ✓ | ✓ | ✗ |
| Canada (TSX, TSXV) | ✗ | ✗ | ✓ | ✓ | ✗ |
| Composite scoring (QVM) | ✓ StockRanks | ✓ StockRanks | ✗ | ✗ | ✗ |
| Raw filter sliders | Partial | Partial | ✓ | ✓ | ✓ |
| Heatmap view | ✗ | ✗ | ✓ | ✗ | ✗ |
| Instant filter response | Partial | Partial | ✓ | Partial | ✗ |
| Analyst consensus data | ✗ | ✗ | ✗ | Partial | ✓ |
Data as of June 2026.
The main Stockopedia alternatives in 2026
ScreenerHero — Best overall replacement
ScreenerHero was built to fill the geographic gap left by UK-weighted screeners. It covers:
- All major European exchanges: XETRA, Euronext Paris, BME, Borsa Italiana, Euronext Amsterdam, Euronext Brussels, Euronext Lisbon
- Nordic exchanges: Nasdaq Stockholm, Nasdaq Copenhagen, Nasdaq Helsinki, Oslo Børs
- Alternative markets: Euronext Growth Paris, Nasdaq First North, EGM Milan, GPW NewConnect
- US: NYSE, NASDAQ — included in all plans, no premium tier required
- Canada: TSX, TSXV
Fundamental filters — P/E, P/B, EV/EBITDA, ROE, ROIC, operating margin, dividend yield, debt/equity — work reliably for European stocks down to microcap level. The interface is desktop-first with instant filter response. Saved screens and heatmap view included on the free tier.
Price: €29/month Pro. Core screener free without account.
Who switches: Stockopedia users who primarily use raw filter sliders rather than StockRanks scores, who need US or Canadian exposure without paying a premium, or who find Stockopedia's price difficult to justify for the continental European small-cap workflow.
What you lose: StockRanks composite scoring. If Stockopedia's QVM system is central to your process, that specific feature does not transfer.
TIKR Pro — Best for historical data depth
TIKR offers 20-year historical financial data and earnings transcripts, which Stockopedia does not. For investors who need to verify a company's multi-decade track record before buying, TIKR Pro's historical depth is a genuine advantage.
Price: $40–55/month (more expensive than ScreenerHero, similar to Stockopedia EU).
Limitation: European microcap fundamental data is thin. Alternative market names (First North, Euronext Growth, EGM) are often listed without usable P/E, ROE, or EV/EBITDA data.
Best for: Investors who do deep fundamental research on large and mid-cap companies globally, where 20-year financials matter more than broad European small-cap coverage.
MarketScreener — Best for analyst consensus
MarketScreener has the deepest analyst consensus and news integration in this comparison, with 300–600 fundamental filters. It covers European markets broadly, including continental names that Stockopedia misses.
Price: ~€30–34/month. Competitive with ScreenerHero.
Limitation: The screener interface requires page reloads on each filter change — significantly slower than modern screener tools. The product is structured around news and analyst reports, with screening as a secondary feature. No US or Canadian coverage. No heatmap.
Best for: Investors who need analyst estimates and news feeds alongside fundamental data, and who are comfortable with a slower, research-report-oriented workflow.
TradingView — Best for chart-driven investors
TradingView has broad European large-cap coverage with good price data. The screener is functional but secondary to charting.
Price: $15–60/month. Account required even for free access.
Limitation: European small-cap and microcap fundamental data is inconsistent. Not designed for systematic fundamental screening — it is a charting tool with a screener added.
Best for: Investors whose primary workflow starts with charts and uses screening occasionally. Not a Stockopedia replacement for fundamental-first investors.